Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2019 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

2 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Refractory Lung Non-Squamous Non-Small Cell Carcinoma"
Page 1
Real-world data on EGFR/ALK gene status and first-line targeted therapy rate in newly diagnosed advanced non-small cell lung cancer patients in Northern China: A prospective observational study.
Liang H, Song X, Zhang Y, Zhang S, Li F, Fang J, Li J, Liang L, Nie L, Ma K, Zhang L, Wang X, Xu J, Wei Y, Wang J, Song Q, Tian G, Mu Y, Gu Y, Yang L, Sun P, Zhong W, Zhao J, Xu Y, Chen M, Wang M. Liang H, et al. Thorac Cancer. 2019 Jul;10(7):1521-1532. doi: 10.1111/1759-7714.13090. Epub 2019 May 29. Thorac Cancer. 2019. PMID: 31144459 Free PMC article.
BACKGROUND: Tyrosine kinase inhibitors (TKIs) can significantly prolong overall survival for patients with advanced non-small cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR)-mutation or anaplastic lymphoma kinase (ALK)-rearra …
BACKGROUND: Tyrosine kinase inhibitors (TKIs) can significantly prolong overall survival for patients with advanced non-small …
The present and future burden of previously treated advanced non-small cell lung cancer (NSCLC) by histology and line of therapy in France, Germany, Italy, and Spain: model-based predictions.
Campbell D, O'Day K, Hertel N, Penrod JR, Manley Daumont M, Lees M. Campbell D, et al. Popul Health Metr. 2018 Nov 26;16(1):17. doi: 10.1186/s12963-018-0174-4. Popul Health Metr. 2018. PMID: 30477516 Free PMC article.
BACKGROUND: The burden of advanced non-small cell lung cancer (NSCLC) is not well understood, and the number of patients likely to receive treatment in Europe has not been quantified. The aim of this study was to forecast the annual number of patients …
BACKGROUND: The burden of advanced non-small cell lung cancer (NSCLC) is not well understood, and the number of …